发明名称 |
1-(5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YL)-3-[2-FLUORO-4-(1-METHYL- 2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-7-YLOXY)-PHENYL]-UREA AND RELATED COMPOUNDS AND THEIR USE IN THERAPY |
摘要 |
PROBLEM TO BE SOLVED: To provide alternative compounds which provide unexpected activity (e.g., activity against mutant RAS cancer) as compared to one or more of structurally-related known compounds.SOLUTION: This invention provides compounds of the formula (I) which, inter alia, are useful in the treatment of cancer, e.g., cancer characterized by (e.g., driven by) mutant RAS ("mutant RAS cancer"). |
申请公布号 |
JP2015180675(A) |
申请公布日期 |
2015.10.15 |
申请号 |
JP20150115366 |
申请日期 |
2015.06.08 |
申请人 |
CANCER RESEARCH TECHNOLOGY LTD;INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL:THE |
发明人 |
CAROLINE SPRINGER;ION NICULESCU-DUVAZ;RICHARD MARAIS;DAN NICULESCU-DUVAZ;ALFONSO ZAMBON;DELPHINE MENARD |
分类号 |
C07D471/04;A61K31/437;A61P35/00;A61P35/02 |
主分类号 |
C07D471/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|